M&T Bank’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,562
Closed -$227K 1574
2025
Q1
$227K Sell
3,562
-862
-19% -$54.9K ﹤0.01% 1369
2024
Q4
$538K Sell
4,424
-38
-0.9% -$4.62K ﹤0.01% 1137
2024
Q3
$558K Buy
4,462
+349
+8% +$43.6K ﹤0.01% 1126
2024
Q2
$650K Sell
4,113
-147
-3% -$23.2K ﹤0.01% 1015
2024
Q1
$551K Buy
4,260
+683
+19% +$88.4K ﹤0.01% 1109
2023
Q4
$345K Sell
3,577
-5
-0.1% -$483 ﹤0.01% 1256
2023
Q3
$435K Buy
3,582
+411
+13% +$49.9K ﹤0.01% 1142
2023
Q2
$363K Buy
3,171
+208
+7% +$23.8K ﹤0.01% 1242
2023
Q1
$409K Sell
2,963
-3,777
-56% -$521K ﹤0.01% 1182
2022
Q4
$873K Sell
6,740
-5
-0.1% -$648 ﹤0.01% 903
2022
Q3
$747K Buy
6,745
+8
+0.1% +$886 ﹤0.01% 927
2022
Q2
$505K Buy
6,737
+183
+3% +$13.7K ﹤0.01% 1003
2022
Q1
$512K Sell
6,554
-412
-6% -$32.2K ﹤0.01% 980
2021
Q4
$627K Buy
6,966
+140
+2% +$12.6K ﹤0.01% 926
2021
Q3
$631K Buy
6,826
+146
+2% +$13.5K ﹤0.01% 908
2021
Q2
$519K Buy
6,680
+607
+10% +$47.2K ﹤0.01% 1022
2021
Q1
$453K Sell
6,073
-329
-5% -$24.5K ﹤0.01% 1047
2020
Q4
$1.09M Sell
6,402
-916
-13% -$156K ﹤0.01% 737
2020
Q3
$1.03M Buy
7,318
+4,554
+165% +$639K 0.01% 693
2020
Q2
$443K Sell
2,764
-99
-3% -$15.9K ﹤0.01% 991
2020
Q1
$279K Sell
2,863
-58
-2% -$5.65K ﹤0.01% 1161
2019
Q4
$377K Buy
2,921
+88
+3% +$11.4K ﹤0.01% 972
2019
Q3
$213K Buy
2,833
+717
+34% +$53.9K ﹤0.01% 1388
2019
Q2
$321K Sell
2,116
-1,940
-48% -$294K ﹤0.01% 1187
2019
Q1
$484K Buy
4,056
+1,077
+36% +$129K ﹤0.01% 981
2018
Q4
$325K Buy
2,979
+114
+4% +$12.4K ﹤0.01% 1084
2018
Q3
$464K Buy
+2,865
New +$464K ﹤0.01% 1029
2016
Q1
Sell
-5,963
Closed -$230K 1708
2015
Q4
$230K Sell
5,963
-1,630
-21% -$62.9K ﹤0.01% 1440
2015
Q3
$244K Buy
+7,593
New +$244K ﹤0.01% 1421
2014
Q4
Sell
-10,500
Closed -$221K 2086
2014
Q3
$221K Buy
+10,500
New +$221K ﹤0.01% 1814